These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10934732)

  • 1. Development and testing of an improved parenteral formulation of phenytoin using 2-hydroxypropyl-beta-cyclodextrin.
    Blanchard J; Ugwu SO; Bhardwaj R; Dorr RT
    Pharm Dev Technol; 2000; 5(3):333-8. PubMed ID: 10934732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of precipitation of phenytoin in an infusion fluid by hydroxypropyl beta-cyclodextrin.
    McDonald C; Muzumdar PP
    J Clin Pharm Ther; 1998 Jun; 23(3):235-9. PubMed ID: 9831976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
    Wu WM; Wu J; Bodor N
    Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a lyophilised RH1 formulation: a novel DT diaphorase activated alkylating agent.
    Elliott MA; Ford SJ; Walker AA; Hargreaves RH; Halbert GW
    J Pharm Pharmacol; 2002 Apr; 54(4):487-92. PubMed ID: 11999125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.
    Mihajlovic T; Kachrimanis K; Graovac A; Djuric Z; Ibric S
    AAPS PharmSciTech; 2012 Jun; 13(2):623-31. PubMed ID: 22535520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.
    Pose-Vilarnovo B; Perdomo-López I; Echezarreta-López M; Schroth-Pardo P; Estrada E; Torres-Labandeira JJ
    Eur J Pharm Sci; 2001 Jun; 13(3):325-31. PubMed ID: 11384856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to reducing toxicity of parenteral anticancer drug formulations using cyclodextrins.
    Bhardwaj R; Dorr RT; Blanchard J
    PDA J Pharm Sci Technol; 2000; 54(3):233-9. PubMed ID: 10927914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid.
    Lin HS; Chean CS; Ng YY; Chan SY; Ho PC
    J Clin Pharm Ther; 2000 Aug; 25(4):265-9. PubMed ID: 10971776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiochemical synthesis and preclinical evaluation of
    Hajdu I; Angyal J; Szikra D; Kertész I; Malanga M; Fenyvesi É; Szente L; Vecsernyés M; Bácskay I; Váradi J; Fehér P; Ujhelyi Z; Vasvári G; Rusznyák Á; Trencsényi G; Fenyvesi F
    Eur J Pharm Sci; 2019 Feb; 128():202-208. PubMed ID: 30521943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of artemisinin and its related compounds with hydroxypropyl-beta-cyclodextrin in solution state: experimental and molecular-modeling studies.
    Illapakurthy AC; Sabnis YA; Avery BA; Avery MA; Wyandt CM
    J Pharm Sci; 2003 Mar; 92(3):649-55. PubMed ID: 12587126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an omeprazole parenteral formulation with hydroxypropyl-beta-cyclodextrin.
    Holvoet C; Heyden YV; Plaizier-Vercammen J
    Pharm Dev Technol; 2007; 12(3):327-36. PubMed ID: 17613896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical properties of carbovir, a potential anti-HIV agent.
    Anderson BD; Chiang CY
    J Pharm Sci; 1990 Sep; 79(9):787-90. PubMed ID: 2273460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation.
    Löscher W; Hönack D; Richter A; Schulz HU; Schürer M; Düsing R; Brewster ME
    Epilepsia; 1995 Mar; 36(3):255-61. PubMed ID: 7614909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubilization and stabilization of a benzylpenicillin chemical delivery system by 2-hydroxypropyl-beta-cyclodextrin.
    Pop E; Loftsson T; Bodor N
    Pharm Res; 1991 Aug; 8(8):1044-9. PubMed ID: 1924158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone.
    Bary AR; Tucker IG; Davies NM
    Eur J Pharm Biopharm; 2000 Sep; 50(2):237-44. PubMed ID: 10962233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
    Holvoet C; Plaizier-Vercammen J; Vander Heyden Y; Gabriëls M; Camu F
    Int J Pharm; 2003 Oct; 265(1-2):13-26. PubMed ID: 14522114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion complex of saikosaponin-d with hydroxypropyl-β-cyclodextrin: Improved physicochemical properties and anti-skin cancer activity.
    Hu SC; Lai YC; Lin CL; Tzeng WS; Yen FL
    Phytomedicine; 2019 Apr; 57():174-182. PubMed ID: 30776588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecalciferol complexation with hydroxypropyl-β-cyclodextrin (HPBCD) and its molecular dynamics simulation.
    Wang F; Yu W; Popescu C; Ibrahim AA; Yu D; Pearson R; MacKerell AD; Hoag SW
    Pharm Dev Technol; 2022 Apr; 27(4):389-398. PubMed ID: 35468028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.